GlassScriptPhysician profile
Richard W Smith
NPI 1194824508
$3,385.93
in general payments reported to CMS, 2019-2025
10 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,890 · 2020: $145 · 2023: $73.92 · 2024: $87.62 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $1,423.00 | 2019 | |
| Stryker Corporation | $1,301.84 | 2019 | |
| Bioventus LLC | $208.33 | 2019-2025 | Durolane, Durolane, Xcell |
| Smith+Nephew, INC. | $185.85 | 2019-2020 | |
| Paragon 28, INC. | $121.41 | 2025 | Bun-Yo-Matic |
| Orthofix Medical, INC. | $42.62 | 2023-2025 | Physio-Stim |
| Vertex Pharmaceuticals Incorporated | $32.85 | 2025 | |
| Ethicon US, LLC | $26.51 | 2019 | |
| Heron Therapeutics, INC. | $22.40 | 2023 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $21.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.